B
Benitec Biopharma D
D
BNTC
14.950
USD
0.42
(2.86%)
مغلق
حجم التداول
10,924
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
392,444,512
العنوان: Benitec Biopharma
القطاع: Healthcare
الصناعة: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.